About this item
Product details
PozeMet is a combination prescription medication containing two anti-diabetic agents: Pioglitazone (15 mg) and Metformin Hydrochloride (850 mg). This powerful dual-therapy approach addresses Type 2 Diabetes in two ways: Pioglitazone improves the body's sensitivity to insulin, while Metformin reduces glucose production in the liver and improves insulin utilization. This combination provides enhanced blood sugar control for patients who need more than one medication to manage their condition. Dual-Mechanism Action: Combines two effective medicines for superior blood glucose control. Improves Insulin Sensitivity: Helps the body respond better to its own insulin. Reduces Liver Glucose Production: Decreases the amount of sugar released by the liver. Convenient Combination: Simplifies your medication regimen with two drugs in one tablet. Composition Each tablet contains: Pioglitazone (as HCI) USP Specs: 15 mg Metformin HCI USP Specs: 850 mg Directions for Use As directed by the physician
- Medicines
- 14 tablets
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- AGP
- SKU
- 8961101540746
- Variant
- 14 tablets
- Tags
- Medicine, Metformin, Pioglitazone, Type 2 Diabetes
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
